Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:06am, Monday, 09'th Jun 2025
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
09:19am, Monday, 09'th Jun 2025
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Pfizer CEO says 'no commitments' made in meetings with US governments on drug pricing
08:33am, Monday, 09'th Jun 2025
Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no commitments have been made, Chief Executive Albert Bourla said on Monday at an indu
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
06:35am, Sunday, 08'th Jun 2025
How would you like to get paid every quarter (and sometimes every month) to own a stock? That's exactly what happens when you invest in dividend stocks.
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 10% (June 2025)
08:00am, Saturday, 07'th Jun 2025
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
Should You Buy Pfizer Stock Right Now?
06:30am, Saturday, 07'th Jun 2025
If you have an opening in your portfolio for a great stock with solid growth potential and perhaps even a respectable dividend yield, you would do well to give Pfizer (PFE 1.04%) some serious consider
Buy 7 Ideal 'Safer' May Dividends, Out Of 40 Reader Tags
09:01am, Friday, 06'th Jun 2025
My yield-based 'dogcatcher' strategy spotlights high-yield stocks whose dividends from $1,000 invested exceed their share price, favoring underdogs for income growth. Analyst targets project average n
5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential
01:11pm, Thursday, 05'th Jun 2025
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like JAKK, GDOT, SIG, ROCK and PFE hold promise.
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis
03:34am, Thursday, 05'th Jun 2025
Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or invest in lower-yield providers with more p
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
03:06am, Thursday, 05'th Jun 2025
It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all
Top 3 dividend stocks to buy for 2026
10:04am, Wednesday, 04'th Jun 2025
Holding dividend stocks remains one of the most effective long-term strategies, with companies that pay a regular dividend often being profitable and well-positioned for future growth, even during eco
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (June 2025)
09:52am, Wednesday, 04'th Jun 2025
Jeff J Mitchell / Getty Images News via Getty Images Pfizer (PFE) Price Prediction 2025–2030 The current consensus one-year price target for Pfizer, according to analysts, is $27.63, which represent
These Stocks Are The High-Yield Dividend Investor's Best Friend
07:05am, Wednesday, 04'th Jun 2025
High-yield stocks are often riddled with flaws. However, there are some high-yield stocks available today that check all of my boxes. I share some of my top high-yield picks of the moment.
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
05:49pm, Tuesday, 03'rd Jun 2025
PHILADELPHIA , June 3, 2025 /PRNewswire/ -- Berger Montague advises shareholders of Pfizer Inc. ("Pfizer" or the "Company") (NYSE: PFE) about an investigation into Pfizer's Board of Directors for po
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
03:34pm, Tuesday, 03'rd Jun 2025
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.
